Literature DB >> 16967334

Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.

Katayun Cohen-Kashi Malina1, Yonatan Ganor, Mia Levite, Vivian I Teichberg.   

Abstract

Autoantibodies to the GluR3-subtype of AMPA/glutamate receptors are found in the sera and cerebrospinal fluid of some individuals with epilepsy. They could possibly play a role in the pathophysiology of epilepsy since anti-GluR3 sera display glutamatergic agonist activity. We have investigated here the ability of affinity-purified antibodies (Abs) directed against the immunogenic peptide GluR3B (amino-acid 372-395) to interact with and activate recombinant GluR3-receptor channels expressed by Xenopus oocytes. We report here that the affinity-purified anti-GluR3B Abs directly activate GluR3-containing homomeric and heteromeric AMPA receptor complexes without the requirement of neuronal, glial or blood ancillary molecules. We present some of the properties of the purified anti-GluR3B Abs and discuss the possible physiological or pathological consequences of their activation of glutamate receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16967334     DOI: 10.1007/s11064-006-9143-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.

Authors:  Renato Mantegazza; Pia Bernasconi; Fulvio Baggi; Roberto Spreafico; Francesca Ragona; Carlo Antozzi; Gaetano Bernardi; Tiziana Granata
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

2.  Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack.

Authors:  Zhi Qi Xiong; James O McNamara
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

Review 3.  Structure and function of AMPA receptors.

Authors:  Eric Gouaux
Journal:  J Physiol       Date:  2003-11-28       Impact factor: 5.182

4.  Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes.

Authors:  N B Karkanias; R L Papke
Journal:  Neurosci Lett       Date:  1999-12-31       Impact factor: 3.046

5.  Subtype-specific effects of lithium on glutamate receptor function.

Authors:  N B Karkanias; R L Papke
Journal:  J Neurophysiol       Date:  1999-04       Impact factor: 2.714

6.  Glutamate receptor GluR3 antibodies and death of cortical cells.

Authors:  X P He; M Patel; K D Whitney; S Janumpalli; A Tenner; J O McNamara
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

7.  GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

Authors:  H Wiendl; C G Bien; P Bernasconi; B Fleckenstein; C E Elger; J Dichgans; R Mantegazza; A Melms
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.

Authors:  S W Rogers; P I Andrews; L C Gahring; T Whisenand; K Cauley; B Crain; T E Hughes; S F Heinemann; J O McNamara
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

9.  Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.

Authors:  R Watson; Y Jiang; I Bermudez; L Houlihan; L Clover; K McKnight; J H Cross; I K Hart; A Roubertie; J Valmier; Y Hart; J Palace; D Beeson; A Vincent; B Lang
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

10.  A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties.

Authors:  N Nakanishi; N A Shneider; R Axel
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

View more
  12 in total

Review 1.  Losing your nerves? Maybe it's the antibodies.

Authors:  Betty Diamond; Patricio T Huerta; Paola Mina-Osorio; Czeslawa Kowal; Bruce T Volpe
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

2.  Dynamics and allosteric potential of the AMPA receptor N-terminal domain.

Authors:  Madhav Sukumaran; Maxim Rossmann; Indira Shrivastava; Anindita Dutta; Ivet Bahar; Ingo H Greger
Journal:  EMBO J       Date:  2011-02-11       Impact factor: 11.598

Review 3.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

Review 4.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

Review 5.  Diagnostic and pathogenic significance of glutamate receptor autoantibodies.

Authors:  David Pleasure
Journal:  Arch Neurol       Date:  2008-05

Review 6.  Brain-reactive antibodies and disease.

Authors:  B Diamond; G Honig; S Mader; L Brimberg; B T Volpe
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

7.  Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice.

Authors:  Francesca Capone; Walter Adriani; Maria Shumilina; Galina Izykenova; Oleg Granstrem; Svetlana Dambinova; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2008-02-12       Impact factor: 4.530

Review 8.  Antibodies as Mediators of Brain Pathology.

Authors:  Lior Brimberg; Simone Mader; Yuichiro Fujieda; Yoshiyuki Arinuma; Czeslawa Kowal; Bruce T Volpe; Betty Diamond
Journal:  Trends Immunol       Date:  2015-10-19       Impact factor: 16.687

9.  Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement.

Authors:  Francesca Cisani; Guendalina Olivero; Cesare Usai; Gilles Van Camp; Stefania Maccari; Sara Morley-Fletcher; Anna Maria Pittaluga
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

10.  Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.

Authors:  Walter Adriani; Susanne Koot; Sandra Columba-Cabezas; Emilia Romano; Domenica Travaglini; Ruud van den Bos; Oleg Granstrem; Syed F Ali; Giovanni Laviola
Journal:  Behav Brain Funct       Date:  2012-11-28       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.